Description
*Retatrutide
Triple GLP-1/GIP/Glucagon receptor agonist peptide
Studied in research for its effects on:
• Glucose-dependent insulin secretion
• Glucagon modulation
• Appetite & satiety signaling
• Gastric emptying
• Energy expenditure (via glucagon receptor)
Activates three key receptors simultaneously, making it a leading tool in advanced metabolic and obesity-related studies.
For research use only. Not for human consumption.






Reviews
There are no reviews yet.